BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17969087)

  • 1. Surveillance and diagnosis for hepatocellular carcinoma.
    Aljabiri MR; Lodato F; Burroughs AK
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S2-12. PubMed ID: 17969087
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
    Nagoshi S; Fujiwara K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
    Everson GT
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular markers for early diagnosis of hepatocellular carcinoma].
    Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow-up studies on hepatoma developing from liver cirrhosis].
    Sakai T; Kishikawa Y
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1637-44. PubMed ID: 1723090
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for hepatocellular carcinoma.
    Haydon GH; Hayes PC
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PIVKA-II as a serological marker of hepatocellular carcinoma].
    Jeong SH
    Korean J Hepatol; 2006 Sep; 12(3):315-7. PubMed ID: 16998285
    [No Abstract]   [Full Text] [Related]  

  • 9. [High risk group for development of hepatocellular carcinoma].
    Koike Y; Shiratori Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
    Compagnon P; Grandadam S; Lorho R; Turlin B; Camus C; Jianrong Y; Lainé F; Meunier B; Deugnier Y; Boudjema K
    Transplantation; 2008 Oct; 86(8):1068-76. PubMed ID: 18946344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new prognostic staging system for hepatocellular carcinoma: value of the biomarker combined Japan integrated staging score.
    Kitai S; Kudo M; Minami Y; Ueshima K; Chung H; Hagiwara S; Inoue T; Ishikawa E; Takahashi S; Asakuma Y; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
    Intervirology; 2008; 51 Suppl 1():86-94. PubMed ID: 18544953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection criteria for patients with hepatocellular carcinoma in liver transplantation.
    Kaido T; Takada Y; Uemoto S
    Transplantation; 2009 Aug; 88(3):442-3; author reply 443. PubMed ID: 19667951
    [No Abstract]   [Full Text] [Related]  

  • 13. New frontiers in biomarkers for hepatocellular carcinoma.
    Giannelli G; Antonaci S
    Dig Liver Dis; 2006 Nov; 38(11):854-9. PubMed ID: 16782417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biological markers of hepatocellular carcinoma].
    Arfaoui D; Elloumi H; Ajmi S
    Tunis Med; 2004 Apr; 82(4):329-34. PubMed ID: 15453027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
    Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
    Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern diagnosis and management of hepatocellular carcinoma.
    Marrero JA; Welling T
    Clin Liver Dis; 2009 May; 13(2):233-47. PubMed ID: 19442916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of imaging in the diagnosis and staging of hepatobiliary malignancies.
    Miller G; Schwartz LH; D'Angelica M
    Surg Oncol Clin N Am; 2007 Apr; 16(2):343-68. PubMed ID: 17560517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCC surveillance: who is the target population?
    Bruix J; Llovet JM
    Hepatology; 2003 Mar; 37(3):507-9. PubMed ID: 12601346
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of small hepatocellular carcinoma.
    Sherman M
    Hepatology; 2005 Jul; 42(1):14-6. PubMed ID: 15962322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.